dose-ranging study

(redirected from Dose-ranging)

dose-ranging study

An investigation of different selected drug dosages to determine if any is better tolerated or more effective than the others.
See also: study
Mentioned in ?
References in periodicals archive ?
The safety and efficacy of the product in paediatric patients was assessed in two paediatric studies of 97 patients with CP-CML: an open-label, non-randomised, dose-ranging trial (NCT00306202) and an open-label, non-randomised, single-arm trial (NCT00777036).
GSK plans to initiate a 12 week, multi-center, dose-ranging, placebo-controlled Phase 2 study investigating safety and efficacy of various doses of GSK2586184 in SLE patients.
Sanofi-aventis recently announced that the results of the TREK dose-ranging study for its new injectable anticoagulant, AVE5026, were presented at the 49th annual meeting of the American Society of Haematology (ASH) in Atlanta.
The Phase I/II dose-ranging trial will take place at The Riverside Hospital in Ottawa, and will involve 50 dyslipidemic patients (patients with low HDL and high LDL).
Tokyo, Japan, Sept 6, 2005 - (JCNN) - Sosei, a Japanese biopharmaceutical company, announced on September 5 that its wholly owned UK subsidiary Arakis has started a phase IIb dose-ranging study of AD 452, an investigational drug for the treatment of rheumatoid arthritis (RA).
M2 PHARMA-May 18, 2015-Adynxx completes patient enrolment in Phase II dose-ranging clinical trial of AYX1
M2 EQUITYBITES-May 18, 2015-Adynxx completes patient enrolment in Phase II dose-ranging clinical trial of AYX1
M2 PHARMA-February 2, 2015-Reata starts enrolling first patient in Phase two dose-ranging study of RTA 408 Oral Capsules
M2 EQUITYBITES-February 2, 2015-Reata starts enrolling first patient in Phase two dose-ranging study of RTA 408 Oral Capsules